← Back to Search

Imaging Technique for Head and Neck Cancer-related Lymphedema

N/A
Waitlist Available
Led By Roman Skoracki
Research Sponsored by Ohio State University Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients with pathologies leading to head and neck lymphedema
Patients of sound mentation, who are able to execute informed decision-making
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 24 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial uses a mobile 3D scanning application to measure the head and neck region in patients with head and neck lymphedema.

Who is the study for?
This trial is for individuals with clear thinking who can make informed decisions, have minimal or no facial hair, and suffer from swelling due to lymph fluid buildup in the head and neck area. People with health issues that could affect the study or a history of not following medical advice are not eligible.
What is being tested?
The trial is testing a new mobile app that uses 3D scanning to measure swelling in patients with head and neck lymphedema. This tool aims to improve how doctors diagnose lymphedema, track treatment responses, and monitor disease progression.
What are the potential side effects?
Since this trial involves an imaging technique rather than medication, traditional side effects like those seen with drugs are not expected. However, there may be unforeseen risks associated with using the mobile application.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have swelling in my head or neck due to a medical condition.
Select...
I am mentally capable of making my own health decisions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 24 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 24 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Average values of the two repeated scans
Patient wellbeing/disease progression
Volume of interest between the cutting planes

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Screening (3D scan)Experimental Treatment1 Intervention
Patients undergo 3D scanning of lower head and neck region over 90-120 seconds before surgery and then every 3 months for up to 1 year after surgery.

Find a Location

Who is running the clinical trial?

Ohio State University Comprehensive Cancer CenterLead Sponsor
342 Previous Clinical Trials
293,107 Total Patients Enrolled
Roman SkorackiPrincipal InvestigatorOhio State University Comprehensive Cancer Center

Media Library

Imaging Technique Clinical Trial Eligibility Overview. Trial Name: NCT05243069 — N/A
Swelling of the head and neck Research Study Groups: Screening (3D scan)
Swelling of the head and neck Clinical Trial 2023: Imaging Technique Highlights & Side Effects. Trial Name: NCT05243069 — N/A
Imaging Technique 2023 Treatment Timeline for Medical Study. Trial Name: NCT05243069 — N/A
~27 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top